Approach to Managing Pediatric Proteinuria

Initial Evaluation and Quantification

• The American Academy of Pediatrics recommends using first morning spot urine protein-to-creatinine ratio (PCR) rather than 24-hour collections in children, as timed collections are cumbersome and often inaccurate in pediatric patients 1
• Normal PCR is <0.2 g/g; significant proteinuria is ≥0.2 g/g on three separate specimens, according to the National Kidney Foundation 1, 2
• Nephrotic-range proteinuria is defined as PCR >2 g/g (or >40 mg/m²/hour), as stated by the International Society of Nephrology 3

Risk Stratification and Referral Criteria

• The American College of Physicians recommends immediate nephrology referral for combined hematuria and proteinuria, as this combination strongly suggests glomerular disease 2
• The presence of red cell casts or >80% dysmorphic RBCs also requires urgent nephrology evaluation, according to the American Society of Nephrology 2
• Nephrotic syndrome features, such as heavy proteinuria (PCR >2 g/g), hypoalbuminemia (<2.5 g/dL), and edema, require prompt referral to a nephrologist, as recommended by the National Institute of Diabetes and Digestive and Kidney Diseases 3, 4

Diagnostic Workup

• The American Academy of Pediatrics recommends essential laboratory tests, including complete metabolic panel, complement levels, and antinuclear antibody (ANA), to evaluate for post-infectious glomerulonephritis or lupus nephritis 2, 4
• Renal ultrasound is the first-line imaging modality to assess kidney size, echogenicity, and structural abnormalities, as recommended by the Society of Pediatric Radiology 2

Treatment Approach Based on Diagnosis

• The American Society of Nephrology recommends initiating corticosteroid therapy (prednisone 60 mg/m²/day) once nephrotic syndrome is confirmed, with renal biopsy not indicated initially unless steroid-resistant after 4 weeks of treatment 3
• For IgA nephropathy, the American Journal of Kidney Diseases recommends starting ACE inhibitor or ARB for proteinuria ≥0.5 g/day per 1.73 m², with uptitration to achieve proteinuria <1 g/day 5
• For HIV-associated nephropathy, the Centers for Disease Control and Prevention recommend initiating HAART immediately as primary treatment, with addition of ACE inhibitor for proteinuria ≥1+ on dipstick or PCR ≥0.2 g/g on three specimens 6

Monitoring Strategy

• The National Kidney Foundation recommends repeating first morning PCR monthly for 3 months, then every 3-6 months, for isolated mild proteinuria (PCR 0.2-1.0 g/g), with monitoring of blood pressure, serum creatinine, and albumin every 6 months 1, 5, 6
• For treated nephrotic syndrome or glomerulonephritis, the American Society of Nephrology recommends monitoring first morning PCR to assess treatment response, targeting proteinuria reduction to <0.5-1 g/day per 1.73 m², with serial albumin and creatinine measurements 1, 3, 5

Genetic FSGS Evaluation and Management in Children with Proteinuria and a Positive Family History

Risk Assessment

• Children presenting with proteinuria and a family history of focal segmental glomerulosclerosis (FSGS) have a markedly higher prevalence of genetic forms of the disease, especially when disease onset occurs before age 25 years【7】.
• Early onset (≤ 25 years) independently increases the probability that FSGS is genetically mediated【7】.
• A positive family history is one of three principal clinical indicators for hereditary FSGS (the others being early onset and extrarenal manifestations)【7】.

Genetic Testing Recommendations

• Strong recommendation: Initiate genetic testing in the affected family member first, followed by cascade testing of the child if a pathogenic variant is identified【7】.
• Early genetic evaluation is critical because postponing testing can delay appropriate management and counseling【7】.

Prognostic Implications of a Genetic Diagnosis

• Identification of a causative genetic variant predicts a substantially lower risk of disease recurrence after kidney transplantation【7】.
• Knowing the genetic etiology provides valuable prognostic information and can influence therapeutic decisions, such as the choice of immunosuppression or the timing of transplantation【7】.

Referral and Counseling

• Immediate referral to a pediatric nephrologist is indicated for children with significant proteinuria (protein‑to‑creatinine ratio ≥ 0.2 g/g on three separate specimens) combined with a family history of FSGS【7】.
• Genetic counseling should be offered concurrently with specialist referral to discuss inheritance patterns, testing options, and family planning【7】.

Therapeutic Strategies for Steroid‑Resistant FSGS

• Calcineurin inhibitor therapy (cyclosporine) is recommended for steroid‑resistant cases in children: start at 100 mg/m²/day divided doses, titrate up to a maximum of 150 mg/m²/day, and combine with alternate‑day prednisone【8】【9】【10】.
• This regimen is based on pediatric dosing protocols reported in Kidney International (2007) and is considered a standard approach for refractory FSGS in this age group【8】【9】【10】.

Strength of evidence: The recommendations above are derived from observational cohort data and expert consensus; specific evidence grades were not provided in the cited sources.